You searched for side effects - Page 73 of 311 - Medivizor
Navigation Menu

Searching for patients with advanced prostate cancer to trial an experimental combination treatment.

Searching for patients with advanced prostate cancer to trial an experimental combination treatment.

Posted by on Dec 13, 2020 in Prostate cancer | 0 comments

In a nutshell This trial is looking to examine the safety and effectiveness of a new drug called CYH33 in combination with olaparib (Lynparza) for the treatment of advanced solid tumors including prostate cancer. The main outcomes that are to be measured are side effects and the response rate to the treatment. This trial is being carried out in Houston,...

Read More

Pomalidomide, bortezomib and dexamethasone for multiple myeloma relapsed after lenalidomide treatment

Pomalidomide, bortezomib and dexamethasone for multiple myeloma relapsed after lenalidomide treatment

Posted by on Dec 13, 2020 in Multiple Myeloma | 0 comments

In a nutshell This study aimed to investigate the outcomes for patients with multiple myeloma (MM) who were treated with pomalidomide (Pomalyst), bortezomib (Velcade), and dexamethasone (Decadron) after relapsing following lenalidomide (Revlimid) treatment.  This study concluded that this treatment combination was effective in...

Read More

Evaluating olaparib for metastatic breast cancer with BRCA1/2 and other gene mutations.

Evaluating olaparib for metastatic breast cancer with BRCA1/2 and other gene mutations.

Posted by on Dec 13, 2020 in Breast cancer | 0 comments

In a nutshell This study was carried out to examine the effectiveness of olaparib (Lynparza) for the treatment of metastatic breast cancer (MBC; cancer that has spread) with gene mutations (abnormalities). The authors found that this treatment was effective for patients with MBC with BRCA1/2 mutations. Some background Breast cancer (BC) is one of the...

Read More

Evaluating long-term outcomes of MRI-guided ultrasound ablation for prostate cancer.

Evaluating long-term outcomes of MRI-guided ultrasound ablation for prostate cancer.

Posted by on Dec 13, 2020 in Prostate cancer | 0 comments

In a nutshell This study was carried out to assess the long-term safety and effectiveness of magnetic resonance imaging (MRI)-guided transurethral ultrasound ablation (TULSA) in patients with localized prostate cancer. The authors found that TULSA was safe and effective, with preserved quality of life. Some background Prostate cancer is one...

Read More

Recombinant human granulocyte colony-stimulating factor and decitabine treatment delay relapse after transplant for patients with acute myeloid leukemia

Recombinant human granulocyte colony-stimulating factor and decitabine treatment delay relapse after transplant for patients with acute myeloid leukemia

Posted by on Dec 12, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate if the combination of recombinant human granulocyte colony-stimulating factor (rhG-CSF; Filgrastim) and decitabine (Dacogen) would be effective in preventing relapse after transplant for patients with high-risk (HR) acute myeloid leukemia (AML).   This study...

Read More

Comparing whole-pelvis vs prostate only radiotherapy in patients with high-risk prostate cancer

Comparing whole-pelvis vs prostate only radiotherapy in patients with high-risk prostate cancer

Posted by on Dec 6, 2020 in Prostate cancer | 0 comments

In a nutshell This study compared the use of radiotherapy for prostate cancer in two areas: the prostate only, or the whole pelvis. The results showed that, for high-risk patients, radiotherapy of the whole pelvis improved patient outcomes. Some background For patients with medium or high-risk prostate cancer, the standard treatment is...

Read More

Certolizumab pegol in rheumatoid arthritis: a 3-year update on safety and effectiveness

Certolizumab pegol in rheumatoid arthritis: a 3-year update on safety and effectiveness

Posted by on Dec 6, 2020 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the long-term effectiveness and safety of certolizumab pegol (Cimzia) in patients with rheumatoid arthritis (RA) from a real-world practice. They found that this medication was safe and patients had a sustained response.  Some background Rheumatoid arthritis (RA) is a chronic condition. It is...

Read More

Does treatment with selinexor, bortezomib and dexamethasone improve the outcome of patients with multiple myeloma?

Does treatment with selinexor, bortezomib and dexamethasone improve the outcome of patients with multiple myeloma?

Posted by on Dec 6, 2020 in Multiple Myeloma | 0 comments

In a nutshell This study investigated if giving patients with aggressive multiple myeloma (MM) a combination of selinexor (Xpovio), bortezomib (Velcade), and dexamethasone (Ozurdex) could improve their survival. The study suggested that this combination improved patients’ outcomes. Some background Multiple Myeloma (MM) is an...

Read More

Evaluating tisagenlecleucel in a real world setting for patients with acute lymphoblastic leukemia and non-Hodgkin lymphoma

Evaluating tisagenlecleucel in a real world setting for patients with acute lymphoblastic leukemia and non-Hodgkin lymphoma

Posted by on Dec 5, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study aimed to investigate the safety and effectiveness of tisagenlecleucel (TL; Kymriah) in a real-world setting as a treatment for acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL).   This study concluded that TL has similar effectiveness and improved safety in a real-world setting when compared to a trial...

Read More

Tisagenlecleucel in a real world setting for patients with acute lymphoblastic leukemia and non-Hodgkin lymphoma

Tisagenlecleucel in a real world setting for patients with acute lymphoblastic leukemia and non-Hodgkin lymphoma

Posted by on Dec 5, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the safety and effectiveness of tisagenlecleucel (TL; Kymriah) in a real-world setting as a treatment for acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL).   This study concluded that TL has similar effectiveness and improved safety in a real-world...

Read More